Inspire is scheduled to present at 12:45 p.m. Eastern Time. The presentation will be accessible via a live webcast here. A webcast replay of the presentation will be available for two weeks following ...
A class action lawsuit was filed against Inspire Medical Systems ($INSP) on November 6, 2025. Plaintiffs in the federal ...
Around 22 million Americans have sleep apnea. Traditional continuous positive airway pressure, or CPAP, machines are the standard treatment. However, they can be loud, uncomfortable and have a pesky ...
Inspire Medical Systems has reported a significant 84% rise in Q1 2023 revenue, reaching $127.9 million, driven by its innovative treatments for Obstructive Sleep Apnea. The company has received FDA ...
Inspire Medical Systems, Inc. (NYSE:INSP) ranks among the best medical device stocks to invest in. On October 10, Inspire Medical Systems, Inc. (NYSE:INSP) published clinical data demonstrating the ...
In recent days, Inspire Medical Systems has been hit by Medicare contractors Noridian and CGS unexpectedly removing CPT code 64568 for hypoglossal nerve stimulation, forcing providers toward an ...
In the fall of last year, I believed that the risk-reward proposition for Inspire Medical (INSP) was improving after shares were lagging, the business became profitable and the FDA granted approval ...
The FDA has labeled a recall of Inspire Medical Systems, Inc.’s (NYSE:INSP) nerve-stimulating implant for obstructive sleep apnea as Class I, the most serious kind. Inspire initiated a recall of its ...
MINNEAPOLIS, June 05, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, ...
As of Thursday, December 18, Inspire Medical Systems, Inc.’s INSP share price has dipped by 23.46%, which has investors questioning if this is right time to buy.
Inspire Medical Systems INSP is preparing to release its quarterly earnings on Monday, 2025-05-05. Here's a brief overview of what investors should keep in mind before the announcement. Analysts ...